Comparison

DUPA(OtBu)-OH European Partner

Item no. TMO-T11122-25mg
Manufacturer TargetMol
CASRN 1026987-94-9
Amount 25 mg
Category
Type Inhibitors
Specific against other
Smiles CC(C)(C)OC(=O)CC[C@@H](C(=O)OC(C)(C)C)NC(=O)N[C@@H](CCC(=O)O)C(=O)OC(C)(C)C
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Available
Short Description
DUPA(OtBu)-OH is a DUPA precursor. DUPA is used as the targeting moiety to actively deliver Docetaxel (DTX) for treatment of Prostate-Specific Membrane Antigen (PSMA) expressing prostate cancer. PSMA has a high affinity for DUPA(Ki = 8 nM).
Shipping
cool pack
Storage
-20°
Molecular Weight
488, 57

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 25 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close